Literature DB >> 23494490

What keeps patients with subarachnoid hemorrhage in the neurosciences ICU?

Bradley A Gross.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23494490     DOI： 10.1007/s12028-013-9829-y

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  7 in total

1.  Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms.

Authors:  A Gruber; K Ungersböck; A Reinprecht; T Czech; C Gross; M Bednar; B Richling
Journal:  Neurosurgery       Date:  1998-02       Impact factor: 4.654

2.  Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage.

Authors:  C Charpentier; G Audibert; F Guillemin; T Civit; X Ducrocq; S Bracard; H Hepner; L Picard; M C Laxenaire
Journal:  Stroke       Date:  1999-07       Impact factor: 7.914

3.  Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome.

Authors:  Aaron S Dumont; R Webster Crowley; Stephen J Monteith; Don Ilodigwe; Neal F Kassell; Stephan Mayer; Daniel Ruefenacht; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Stroke       Date:  2010-09-02       Impact factor: 7.914

4.  Hospital resource utilization in the treatment of cerebral aneurysms.

Authors:  K D Yundt; R G Dacey; M N Diringer
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

5.  Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?

Authors:  A J P Goddard; P P J Raju; A Gholkar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

6.  Impact of ruptured cerebral aneurysm coiling and clipping on the incidence of cerebral vasospasm and clinical outcome.

Authors:  O O Zaidat; C C Ionita; S I Hussain; M J Alexander; A H Friedman; C Graffagnino
Journal:  J Neuroimaging       Date:  2008-08-04       Impact factor: 2.486

7.  Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Authors:  R Loch Macdonald; Neal F Kassell; Stephan Mayer; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Aline Frey; Sebastien Roux; Alberto Pasqualin
Journal:  Stroke       Date:  2008-08-07       Impact factor: 7.914
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.